Glycemic screening and recurrent carbohydrate metabolism disorders with endocrine pathology
Journal Title: Міжнародний ендокринологічний журнал - Year 2018, Vol 14, Issue 2
Abstract
The use of glycated hemoglobin for diabetes mellitus (DM) diagnosis is recommended by World Health Organization as of 2011. The level of glycated hemoglobin (HbA1c) ≥ 6.5 % is a diagnostic criterion for DM but HbA1c level of 6.0–6.4 % does not exclude diabetes mellitus diagnosis with hyperglycemia. Moreover, when diagnosing, evaluation of this criterion is a must, since decision about the nature and the scope of sugar-reducing therapy is based on the level of HbA1c. Counterregulatory hormones are glucagon, adrenalin, somatotropin, glucocorticoids and thyroid hormones. Pathogenic mechanism of carbohydrate metabolism disorders with hypersecretion of counterregulatory hormones is caused by peripheral insulin resistance, decrease in insulin secretion, increase in gluconeogenesis and glycogenolysis in liver and increase in the absorption of intestinal glucose with insulin being the only hormone decreasing the blood glucose. So, the endocrine diseases (hypercorticism, acromegalia, pheochromocytoma, hyperparathyroidism and hyperthyroidism) with excessive secretion of counterregulatory hormones suggest the necessity of secondary diabetes diagnosis. Screening tests with quite high sensitivity and specificity have been developed for early diagnosis of endocrynopathies. Screening tests for hypercorticism diagnosis are dexamethasone (1 mg) suppression test, daily urinary cortisol excretion and nighttime salivary cortisol. Optimal test for screening acromegalia is considered to be insulin-like growth factor 1 which shows the secretion of somatotropic hormone during previous day and is not subject to significant fluctuations. One-time detection of increased insulin-like growth factor 1 level compared to referential values for specific sex and age is enough for confirmation of hypersomatotropinemia. Thyroid-stimulating hormone is recommended as a screening test for thyrotoxicosis diagnosis. When choosing this test, doctor should consider the parameter of analytical sensitivity of test system for thyroid-stimulating hormone. Screening for hyperparathyroidism is the detection of blood ionized calcium level. This examination is particularly relevant for patients from risk group for initial hyperparathyroidism — patients with gallstone disease, urolithiasis, stomach ulcer and/or duodenal ulcer, essential hypertension, etc. Free metanephrines of blood plasma and conjugated urine metanephrines are the screening tests for pheochromocytoma diagnosis. The level of methylated secondary catecholamines (metanephrines, normetanephrines) shows the daily tumor activity of pheochromocytoma. Thus, glycemic screening and endocrynopathies screening with hypersecretion of counterregulatory hormones should be conducted together. This will allow detecting secondary forms of diabetes mellitus and compensating glycemic state of the patient.
Authors and Affiliations
L. A. Lutsenko
Keywords
Related Articles
- EP ID EP299709
- DOI 10.22141/2224-0721.14.2.2018.130568
- Views 60
- Downloads 0
Essential microelement contents in the blood plasma of children with biologically inactive growth hormone syndrome
Background. The purpose was to increase the effectiveness of treatment in children and adolescents with biologically inactive growth hormone syndrome (BIGHS) based on studying the content of essential microelements (EM)...
Cerebrovascular Disorders in Women with Overweight and Obesity
Cerebrоvascular diseases are one of the most maladaptive disorders in both men and women. Meanwhile, in the female population when compared to men, strokes occur much later. Strokes in women have higher incidence of trad...
Hormonal and Biochemical Parameters in Pregnant Women with Fetal Distress
Antenatal fetal death is an actual clinical problem. It consists 77.9 % among stillborn children. Assuming that all surveyed pregnant women had a history of antenatal fetal death, it was held hormonal examination of plac...
Monitoring the status of the blood circulation in the lower extremities in patients with diabetes mellitus
Background. Diabetes mellitus (DM) is a current medical and social problem. According to the data from International Diabetes Federation, 415 million people worldwide suffer from DM, and bу 2030, the number of patients i...
Combined Therapy with Antihyperglycemic Oral Agents (Metformin, Sulfonylureas) and Insulin in the Management of Type 2 Diabetic Patients (Pathogenic Substantiation and Clinical Utility)
The review deals with the prospect substantiation for using combined therapy by oral antihyperglycemic drugs with different mechanisms of action (metformin + sulfonylureas) and insulin for type 2 diabetes mellitus. The s...